Romark Global Pharma, LLC

Pharmaceutical product distributor

Based in PR

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $290K in lobbying spend across 10 quarterly filings, Romark Global Pharma, LLC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2024.

$290K
Total Spend
3
Years Active
1
Firms Hired
6
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$20K
2023$270K
2024$0

Issues Lobbied

Pharmacy

Lobbying Firms

Brownstein Hyatt Farber Schreck, LLP

Lobbyists

Sohil KhuranaAdam SteinmetzEdward RoyceEmily FelderLaura BollierGregory Sunstrum

Government Agencies Targeted

These are the government entities that Romark Global Pharma, LLC disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy

Issues regarding funding for Biomedical Advanced Research and Development Authority

Issues regarding Biomedical Advanced Research and Development Authority H.R. 2617, Consolidated Appropriations Act, 2023

Issues regarding Biomedical Advanced Research and Development Authority Covid-19 Therapeutics'

Issues regarding Biomedical Advanced Research and Development Authority Covid-19 Therapeutics' Pandemic All Hazards Prepardness Act

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Brownstein Hyatt Farber Schreck LLP Obo Romark Global Pharma, LLC
$0 total spend
Government of Puerto Rico
$2.9M total spend
Triple-s Management Corporation
$2.3M total spend
Financial Oversight and Management Board for Puerto Rico
$1.9M total spend
Medicaid and Medicare Advantage Products Association of Puerto Rico
$1.8M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.